Synthace

Synthace, established in 2011 and headquartered in the United Kingdom, is making significant strides in the biotech industry with its advanced software solutions. Positioned within the Automation, Biotechnology, Life Sciences, and Pharmaceutical sectors, Synthace offers an innovative, end-to-end software platform designed to empower scientists. Their tools facilitate the design, automation, and analysis of complex experiments, streamlining processes to derive faster and more meaningful biological insights.

The company's mission, encapsulated in their slogan—"Helping scientists solve the world's most pressing problems with faster, more powerful experiments."—speaks to their commitment to elevating scientific research.

Their latest funding round, a $35.00M Series C investment in November 2021, was backed by prominent investors such as SOSV, Sofinnova Partners, and Horizons Ventures. This financial backing highlights the confidence investors have in Synthace's potential to revolutionize life sciences research.